![Nadir Mahmood](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nadir Mahmood
Directeur Financier/CFO chez
NKARTA, INC.
Fortune : 335 488 $ au 31/05/2026
Profil
Nadir Mahmood is currently Director at California Life Sciences Association since 2021.
Dr. Mahmood is also President, Chief Financial & Accounting Officer at Nkarta, Inc. starting in 2025.
Formerly, Dr. Mahmood was Chief Executive Officer & Director at Rezo Therapeutics, Inc. from 2023 to 2024.
Dr. Mahmood was Chief Financial & Business Officer at Nkarta, Inc. from 2020 to 2023.
Dr. Mahmood was Senior Director-Corporate Development at Second Genome, Inc. from 2016 to 2017.
Dr. Mahmood was Staff Scientist at Kythera Biopharmaceuticals LLC from 2007 to 2009.
Education includes undergraduate degree from The University of Texas at Austin and doctorate from The University of Texas Southwestern Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NKARTA, INC. 0,14% | 17/04/2026 | 103 227 ( 0,14% ) | 335 488 $ | 31/05/2026 |
Postes actifs de Nadir Mahmood
| Sociétés | Poste | Début |
|---|---|---|
| NKARTA, INC. | Directeur Financier/CFO | 31/03/2025 |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Directeur/Membre du Conseil | 09/03/2021 |
Anciens postes connus de Nadir Mahmood
| Sociétés | Poste | Fin |
|---|---|---|
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Directeur Général | 01/06/2024 |
| NKARTA, INC. | Directeur Financier/CFO | 30/06/2023 |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Corporate Officer/Principal | 01/05/2017 |
| KYTHERA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 01/07/2009 |
Formation de Nadir Mahmood
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes novel dermatology prescription drugs | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Health Technology |
Nkarta, Inc.
 Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Commercial Services |
